Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Armata Pharmaceuticals (ARMP) Earnings Date, Estimates & Call Transcripts

Armata Pharmaceuticals logo
$7.60 -0.45 (-5.59%)
Closing price 05/18/2026 04:10 PM Eastern
Extended Trading
$7.75 +0.15 (+1.97%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Armata Pharmaceuticals Earnings Summary

Armata Pharmaceuticals issued Q1 2026 earnings on May 13, 2026, reporting an EPS of -$3.16, which missed analysts' consensus estimates of -$0.38 by $2.78. Quarterly revenue was reported to be $0.79 million, above the consensus estimate of $0.74 million. Armata Pharmaceuticals currently has a trailing EPS of -$1.64

Q1 2026 Earnings Resources

Latest Q1 2026
Earnings Date
May. 13Estimated
Consensus EPS
(May. 13)
-$0.38
Actual EPS
(May. 13)
-$3.16 Missed By -$2.78
Actual Revenue
(May. 13)
$0.79M
Get Armata Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Armata Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ARMP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ARMP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Armata Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20261-$0.48-$0.48-$0.48
Q3 20261-$0.53-$0.53-$0.53
Q4 20261-$0.52-$0.52-$0.52

Armata Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/13/2026Q1 2026-$0.38-$3.16 -$2.78-$3.16$0.74M$0.79M
3/25/2026Q4 2025-$0.19-$3.42 -$3.23-$3.42$0.74M$1.09M
8/13/2024Q2 2024-$0.52-$0.65 -$0.13-$1.05--

Data powered by Fiscal.ai.

Armata Pharmaceuticals Earnings - Frequently Asked Questions

Armata Pharmaceuticals (NYSEAMERICAN:ARMP) last announced its quarterly earning data on Wednesday, May 13, 2026. Learn more on ARMP's earnings history.

In the previous quarter, Armata Pharmaceuticals (NYSEAMERICAN:ARMP) missed the analysts' consensus estimate of ($0.38) by $2.78 with a reported earnings per share (EPS) of ($3.16). Learn more on analysts' earnings estimate vs. ARMP's actual earnings.

Armata Pharmaceuticals (NYSEAMERICAN:ARMP) has a recorded annual revenue of $4.90 million.

Armata Pharmaceuticals (NYSEAMERICAN:ARMP) has a recorded net income of -$173.80 million. ARMP has generated -$1.64 earnings per share over the last four quarters.


This page (NYSEAMERICAN:ARMP) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners